Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115372223 | 11537222 | 3 | F | 20160711 | 20150922 | 20160719 | PER | PHEH2015US017973 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160719 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115372223 | 11537222 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, UNK | U | 21588 | 400 | MG | |||||||
115372223 | 11537222 | 2 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 600 MG, QD | U | S0014 | 21588 | 600 | MG | QD | |||||
115372223 | 11537222 | 3 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Unknown | 100 MG, TID | U | 0 | 100 | MG | TID | ||||||
115372223 | 11537222 | 4 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Unknown | UNK (REPORTED AS 4, 2 AM/2 PM) | U | 0 | QD | ||||||||
115372223 | 11537222 | 5 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Unknown | 2 DF, QD (2 DAILY IN PM) | U | 0 | 2 | DF | QD | ||||||
115372223 | 11537222 | 6 | C | ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
115372223 | 11537222 | 7 | C | KLONOPIN | CLONAZEPAM | 1 | Oral | 6 DF, QD | Y | 0 | 6 | DF | QD | ||||||
115372223 | 11537222 | 8 | C | KLONOPIN | CLONAZEPAM | 1 | Oral | 4 DF, QD | Y | 0 | 4 | DF | QD | ||||||
115372223 | 11537222 | 9 | C | KLONOPIN | CLONAZEPAM | 1 | Oral | 3 DF, QD | Y | 0 | 3 | DF | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
115372223 | 11537222 | 1 | Neoplasm malignant |
115372223 | 11537222 | 3 | Depression |
115372223 | 11537222 | 4 | Depression |
115372223 | 11537222 | 5 | Sleep disorder |
115372223 | 11537222 | 6 | Diabetes mellitus |
115372223 | 11537222 | 7 | Depression |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
115372223 | 11537222 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
115372223 | 11537222 | Abdominal pain | |
115372223 | 11537222 | Bone pain | |
115372223 | 11537222 | Confusional state | |
115372223 | 11537222 | Decreased appetite | |
115372223 | 11537222 | Diarrhoea | |
115372223 | 11537222 | Fatigue | |
115372223 | 11537222 | Fluid retention | |
115372223 | 11537222 | Haemorrhage | |
115372223 | 11537222 | Memory impairment | |
115372223 | 11537222 | Mental impairment | |
115372223 | 11537222 | Muscle spasms | |
115372223 | 11537222 | Nausea | |
115372223 | 11537222 | Pain | |
115372223 | 11537222 | Rash | |
115372223 | 11537222 | Red blood cell count decreased | |
115372223 | 11537222 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |